XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Loss Per Share (Tables)
 6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The calculation of basic and diluted loss per share was as follows for the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Numerator:
Net loss$(95,835)$(165,314)$(206,192)$(342,878)
Less: Redeemable preferred stock dividends
(10,079)(10,079)(20,047)(20,047)
Net loss attributable to common stockholders – basic and diluted$(105,914)$(175,393)$(226,239)$(362,925)
Denominator:
Weighted average common stock outstanding – basic910,046,750 365,036,365 881,608,165 241,282,003 
Weighted average common stock outstanding – diluted910,046,750 365,036,365 881,608,165 241,282,003 
Loss per share – basic$(0.12)$(0.48)$(0.26)$(1.50)
Loss per share – diluted$(0.12)$(0.48)$(0.26)$(1.50)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
We excluded the effect of the below elements from our calculation of diluted loss per share, as their inclusion would have been anti-dilutive, as there were no earnings attributable to common stockholders. These amounts represent the number of instruments outstanding at the end of each period indicated:
June 30,
20222021
Common stock options
19,634,712 27,040,727 
Common stock warrants
12,170,990 40,295,990 
Unvested RSUs
60,741,866 53,128,121 
Unvested PSUs
21,797,374 6,428,578 
Convertible notes(1)
53,538,000 — 
Contingent common stock(2)
6,903,663 320,649 
Potentially issuable contingent common stock(3)
598,068 — 
________________________
(1)Represents the number of common stock issuable upon conversion of all convertible notes at the conversion rate in effect at the date indicated.
(2)As of June 30, 2022, includes contingently returnable common stock in connection with the Technisys Merger, which remains subject to further adjustment, pending final agreement regarding a closing net working capital calculation specified in the merger agreement. See Note 2 for additional information. As of June 30, 2021, included contingently issuable common stock in connection with our acquisition of 8 Limited, which was subsequently issued during the fourth quarter of 2021.
(3)As of June 30, 2022, includes the maximum amount of potentially issuable contingent common stock in connection with the Technisys Merger, which is pending final agreement regarding a closing net working capital calculation specified in the merger agreement. See Note 2 for additional information.